The article on SlOOA4 and prostate cancer in the January 1, 2005, issue of Clinical Cancer Research was incorrectly labeled a report from the Food and Drug Administration. The article has no connection to the Food and Drug Administration.
Saleem M, Adhami V, Ahmad N, et al. Prognostic significance of metastasis-associated protein SIOOA4 (Mts1) in prostate cancer progression and chemoprevention regimens in an autochthonous mouse model. Clin Cancer Res 2005;11:147–55.
American Association for Cancer Research
2005
RSS Feeds